Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell transplantation in acute leukemia

S J Forman1

  • 1Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA 91010, USA.

Current Opinion in Oncology
|February 18, 1998
PubMed
Summary

Allogeneic transplantation offers a cure for acute leukemia through graft-versus-tumor effects. Advances in stem cell sources and molecular assessments enhance treatment effectiveness and reduce toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.

Leukemia·2016
Same author

Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus.

Bone marrow transplantation·2014
Same author

Sclerodermatous chronic GVHD in patients receiving tyrosine kinase inhibitors after allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2014
Same author

Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation.

Bone marrow transplantation·2014
Same author

Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase.

Gene therapy·2013

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Hematopoietic stem cell transplantation (HSCT) is a curative option for acute leukemia.
  • Allogeneic HSCT leverages graft-versus-tumor (GVT) effects for leukemia eradication.
  • Donor leukocyte infusions can treat relapsed leukemia post-allogeneic HSCT.

Purpose of the Study:

  • To review advancements in allogeneic and autologous transplantation for acute leukemia.
  • To highlight expanded cellular sources and improved monitoring techniques.
  • To discuss strategies for enhancing HSCT efficacy and reducing toxicity.

Main Methods:

  • Review of research in histocompatibility and stem cell biology.
  • Application of molecular studies for minimal residual disease assessment.
  • Analysis of preparative regimens including targeted radioimmunotherapy and pharmacokinetics.

Main Results:

  • Expanded donor sources include matched unrelated donors, cord blood, and peripheral blood stem cells.
  • Molecular monitoring allows for pre-emptive intervention before overt relapse.
  • Optimized preparative regimens show potential for improved outcomes.

Conclusions:

  • Allogeneic transplantation remains a cornerstone in acute leukemia treatment.
  • Innovations in stem cell sources, disease monitoring, and preparative regimens are improving HSCT.
  • Further research aims to maximize therapeutic benefits while minimizing treatment-related toxicities.

Related Experiment Videos